Davidoula Georgopoulou
Class of 2024Arta, Epirus
About
Hello! My name is Davidoula and I am from Arta, Greece. My Polygence project is on axon regeneration at the central nervous system. I decided to do research because of the brain. It is a miraculous organ. I like how it can heal by itself and adjust. I would like to showcase my project by publishing it to journals .Project Portfolio
Designing the Future of Healthcare: A deep dive into innovation and problem-solving
Started June 14, 2024
Abstract or project description
Innovating in healthcare is a complex endeavor that involves multiple stakeholder groups from the patient to the patient’s family or caregivers, to scientists and engineers, to clinicians, to payers, to business and finance, to designers, to government, and to industry. Human-centered design thinking is used in problem-solving to build and accelerate biomedical and healthcare innovations. We will cover the history and basis behind design thinking, its role for problem-solving in medicine and healthcare, and how it has contributed to the ideation, design, development, and scaling of new healthcare services, devices, diagnostics, and therapeutics. This is a highly interactive pod where students will have the opportunity to dive deep through case studies on novel healthcare technologies, services, startups, or therapeutics of their choosing. Students will learn how to identify relevant sources of information, perform literature reviews, identify the intellectual property and regulatory landscape, interview stakeholders engaged in the development of these technologies, and learn more about the latest cutting-edge healthcare innovations.
Project Portfolio
Pathophysiology characteristics of spinal cord injuries and potential treatments
Started Feb. 6, 2023
Abstract or project description
Understanding SCI pathophysiology including some of its consequent event sequences during and post-injury is of vital importance in designing an appropriate intervention for SCI. Current therapeutic approaches are broadly classified as neuroprotective, neuro-regenerative, and immune-modulating pathways which will be discussed in detail in this review article. However, there is still a need for more efficient drug-delivery systems providing neuroprotective and neuro-regenerative agents (or their combinations) of available SCI treatments. Considering the financial and physical burden of SCI, developing a combinative approach utilizing neuroprotective and neuro-regenerative strategies to simultaneously target multiple pathways will be a valuable treatment option for many populations.